Elaine Whitaker died unexpectedly and peacefully on March 31, 2020. Dr. Whitaker was born in Oklahoma City, OK, and grew up in Little Rock, [...]
(Hackensack, NJ, April 2020) --The Consortium of Multiple Sclerosis Centers (CMSC) and the National Multiple Sclerosis Society have [...]
COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the Consortium of MS Centers (CMSC) and the National MS [...]
The Plegridy (peginterferon beta-1a) Prescribing Information and the Avonex (interferon beta-1a) Prescribing Information was updated in the [...]
(Hackensack, NJ, March 2020) --The Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting scheduled for May 27-30, 2020 in [...]
The U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral capsules to treat adults with relapsing forms [...]
Paris, France, March 10, 2020 – MedDay Pharmaceuticals announced today that the second pivotal Phase III trial (SPI2) of its [...]
The Centers for Disease Control and Prevention (CDC) are following the outbreak of coronavirus (COVID-19), which causes a respiratory [...]
Dear Colleagues and Clients: We know you are interested in what happens to people with MS and related diseases who develop [...]
As part of our commitment to ensuring healthy lives and promote well-being, we are providing you a list of resources related to coronavirus [...]